• Dayssy A. Diaz
  • Alan Pollack
  • Matthew C. Abramowitz


Prior to treatment, an adequate staging workup should be performed. Complete H&P including scrotal and testicular examination, serum tumor markers (α-fetoprotein, β-human chorionic gonadotropin, and LDH), scrotal ultrasound, CT of the abdomen and pelvis, and CXR


Serum Tumor Marker Pelvic Recurrence Target Delineation Iliac Region Sperm Banking 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Warde P, Huddart R, Bolton D et al (2011) Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology 78:S435–S443PubMedCrossRefGoogle Scholar
  2. 2.
    Fossa SD, Horwich A, Russell JM et al (1999) Optimal planning target volume for stage I ­testicular seminoma: a Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol 17:1146PubMedGoogle Scholar
  3. 3.
    Jones WG, Fossa SD, Mead GM et al (2005) Randomized trial of 30 versus 20 Gy in the ­adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 23:1200–1208PubMedCrossRefGoogle Scholar
  4. 4.
    Albers P, Albrecht W, Algaba F et al (2012) EAU guidelines on testicular cancer: 2011 update. Actas Urol Esp 36(3):127–145PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Dayssy A. Diaz
    • 1
  • Alan Pollack
    • 1
  • Matthew C. Abramowitz
    • 1
  1. 1.Department of Radiation Oncology, Sylvester Comprehensive Cancer CenterUniversity of Miami, Miller School of MedicineMiamiUSA

Personalised recommendations